Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multifocal motor neuropathy.

E Nobile-Orazio1

  • 1"Giorgio Spagnol" Service of Clinical Neuroimmunology, Dino Ferrari Centre, Department of Neurological Sciences, University of Milan, IRCCS Ospedale Maggiore Policlinico, Via Francesco Sforza 35, 20122, Milan, Italy. eduardo.nobile@unimi.it

Journal of Neuroimmunology
|April 3, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Response to: SARS-CoV-2 associated Guillain-Barré syndrome in 62 patients.

European journal of neurology·2020
Same author

Chronic inflammatory demyelinating polyradiculoneuropathy: can a diagnosis be made in patients not fulfilling electrodiagnostic criteria?

European journal of neurology·2020
Same author

Guillain-Barré syndrome associated with SARS-CoV-2 infection. A systematic review.

European journal of neurology·2020
Same author

Chronic immune sensory polyradiculopathy (CISP): First juvenile case description.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2020
Same author

Risk factors for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): antecedent events, lifestyle and dietary habits. Data from the Italian CIDP Database.

European journal of neurology·2019
Same author

Corticosteroids in chronic inflammatory demyelinating polyneuropathy : A retrospective, multicentre study, comparing efficacy and safety of daily prednisolone, pulsed dexamethasone, and pulsed intravenous methylprednisolone.

Journal of neurology·2018
Same journal

Peripheral redox biomarkers in multiple sclerosis: associations with phenotype, cognition, and fatigue.

Journal of neuroimmunology·2026
Same journal

Comparison of mannitol versus pertussis toxin to exacerbate active experimental autoimmune encephalomyelitis (EAE).

Journal of neuroimmunology·2026
Same journal

Thymectomy promotes maintained complete stable remission in myasthenia gravis.

Journal of neuroimmunology·2026
Same journal

Spinal cord microglia exhibit a dysfunctional response to myelin damage.

Journal of neuroimmunology·2026
Same journal

Methodological concerns in the cutoff determination of a flow cytometric MOG-IgG assay: The need for independent validation.

Journal of neuroimmunology·2026
Same journal

Clinical features, imaging findings, and treatment outcomes of optic neuritis associated with anti-CRMP5 antibodies: a systematic review.

Journal of neuroimmunology·2026
See all related articles

Multifocal motor neuropathy (MMN) is an immune-mediated peripheral nerve disorder causing progressive limb weakness. Intravenous immunoglobulin therapy (IVIg) offers significant, though transient, improvement for most MMN patients.

Area of Science:

  • Neurology
  • Immunology
  • Peripheral Nervous System Disorders

Background:

  • Multifocal motor neuropathy (MMN) is a distinct peripheral nerve disorder.
  • Characterized by progressive, asymmetric limb weakness, primarily in upper limbs, with minimal sensory loss.
  • Diagnosis relies on nerve conduction studies showing conduction blocks in motor nerves.

Purpose of the Study:

  • To review the current understanding of Multifocal Motor Neuropathy (MMN).
  • To discuss the potential immunological basis and diagnostic markers of MMN.
  • To evaluate current therapeutic strategies and identify areas needing further research.

Main Methods:

  • Review of existing literature on MMN.
  • Analysis of clinical characteristics and diagnostic criteria.

Related Experiment Videos

  • Evaluation of treatment outcomes for various therapies including IVIg and interferon-beta.

    • Main Results:

    • MMN is suspected to have an immunological basis, with anti-ganglioside antibodies (GM1, GM2, GD1a) frequently detected.
    • Steroids and plasma exchange are generally ineffective, and cyclophosphamide has limited efficacy and side effects.
    • High-dose intravenous immunoglobulin (IVIg) therapy provides rapid, significant improvement in over 80% of patients, but requires maintenance infusions.
    • Interferon-beta shows promise in a subset of patients, including those resistant to IVIg.

    Conclusions:

    • IVIg is the primary effective treatment for MMN, despite its transient nature.
    • Further research is needed to clarify MMN's nosological position, precise etiopathogenesis, and optimal long-term management.
    • Understanding the role of antibodies and exploring alternative therapies like interferon-beta are crucial for advancing MMN care.